top of page
$CVM CEL-SCI Enters Strategic Agreement with Amarox for the Registration, Commercialization, and Distribution of Multikine in Saudi Arabia
50%/50% revenue sharing agreement for Multikine sales in Saudi Arabia upon receipt of Breakthrough Medicine Designation Amarox to act as the local regulatory representative and lead all communications with the Saudi Food and Drug Authority (SFDA) Amarox ranked #1 for SFDA applications for critical and unavailable medicine for 3 consecutive years Amarox to be exclusive commercial distributor of Multikine in Saudi Arabia, upon SFDA approval, with optional expansion to GCC coun
🚨StockOnHighAlert🚀
1 day ago5 min read
bottom of page